Company intelligence / Profile preview

Rovii Biotech

Ownership: Private
Employees: ~100
Development stage: Other

Overview

Rovii Biotech is a specialized life science tools company focused on the development of microfluidic technologies and digital PCR (dPCR) systems. The company provides high-precision instruments for absolute nucleic acid quantification, which are utilized in liquid biopsy, single-cell analysis, and pathogen detection. Their core technology, the DropX platform, leverages droplet microfluidics to offer high sensitivity and throughput for clinical and research applications. Rovii Biotech aims to advance precision medicine by making complex molecular analysis more accessible and efficient. The company serves a global market, providing solutions for oncology, infectious disease monitoring, and reproductive health.

Therapeutic areas: OncologyRare DiseasesInfectious Diseases
Modalities: Device
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Rovii Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rovii Biotech.